 TORONTO, June 02, 2022 GLOBE NEWSWIRE -- Profound Medical Corp. NASDAQ:PROF; TSX:PRN Profound or the Company, a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Companys business at the 2022 Jefferies Global Healthcare Conference in New York City on Thursday, June 9, 2022 at 4:30 p.m. Eastern Time. 